Your browser is no longer supported. Please, upgrade your browser.
Settings
TARO Taro Pharmaceutical Industries Ltd. daily Stock Chart
TARO [NYSE]
Taro Pharmaceutical Industries Ltd.
Index- P/E- EPS (ttm)-6.74 Insider Own36.60% Shs Outstand38.26M Perf Week-1.33%
Market Cap2.39B Forward P/E- EPS next Y- Insider Trans0.00% Shs Float8.76M Perf Month-3.89%
Income-256.90M PEG- EPS next Q-7.43 Inst Own12.60% Short Float1.47% Perf Quarter-6.12%
Sales601.10M P/S3.97 EPS this Y-12.10% Inst Trans-0.23% Short Ratio3.99 Perf Half Y-18.02%
Book/sh44.00 P/B1.44 EPS next Y- ROA-11.10% Target Price82.00 Perf Year-21.99%
Cash/sh29.75 P/C2.13 EPS next 5Y-12.95% ROE-13.00% 52W Range56.07 - 99.69 Perf YTD-28.07%
Dividend- P/FCF10.40 EPS past 5Y-10.90% ROI9.20% 52W High-37.62% Beta0.88
Dividend %- Quick Ratio2.30 Sales past 5Y-5.70% Gross Margin60.40% 52W Low10.91% ATR2.05
Employees1464 Current Ratio2.60 Sales Q/Q-27.10% Oper. Margin-45.10% RSI (14)37.75 Volatility2.99% 2.77%
OptionableYes Debt/Eq0.00 EPS Q/Q-762.00% Profit Margin-42.70% Rel Volume0.54 Prev Close63.25
ShortableYes LT Debt/Eq0.00 EarningsJul 29 AMC Payout- Avg Volume32.37K Price62.19
Recom2.00 SMA20-5.06% SMA50-6.42% SMA200-15.97% Volume12,190 Change-1.68%
Jul-27-20Reiterated H.C. Wainwright Buy $96 → $82
Feb-04-20Reiterated H.C. Wainwright Buy $110 → $94
Nov-05-19Reiterated H.C. Wainwright Buy $105 → $110
Mar-12-18Initiated H.C. Wainwright Buy $124
May-23-17Downgrade Credit Suisse Outperform → Neutral
Jul-29-20 06:55PM  
05:00PM  
Jul-23-20 04:32PM  
Jul-22-20 02:37PM  
Jun-25-20 06:45PM  
Jun-19-20 09:30AM  
May-29-20 05:41PM  
May-20-20 06:00AM  
May-19-20 06:45PM  
05:30PM  
May-12-20 07:37PM  
May-06-20 10:09AM  
Apr-06-20 12:26PM  
Mar-27-20 10:46AM  
Mar-22-20 10:35AM  
Mar-04-20 04:33PM  
Feb-20-20 05:54PM  
Feb-05-20 12:45PM  
04:03AM  
Feb-03-20 06:35PM  
05:21PM  
Jan-28-20 06:19PM  
Jan-16-20 12:44PM  
Jan-10-20 03:00PM  
Dec-19-19 06:27PM  
04:42PM  
Dec-17-19 09:23PM  
Dec-16-19 03:55PM  
Dec-06-19 08:45AM  
Nov-29-19 08:39AM  
Nov-22-19 12:03AM  
Nov-15-19 08:00AM  
Nov-04-19 08:15PM  
05:02PM  
Oct-28-19 10:31AM  
Oct-25-19 03:50PM  
Oct-24-19 03:02PM  
Oct-15-19 01:09PM  
Oct-09-19 07:58AM  
Aug-30-19 10:59AM  
Aug-09-19 03:07PM  
Aug-08-19 05:00PM  
Aug-01-19 10:33AM  
Jul-31-19 03:31PM  
Jul-16-19 12:04PM  
Jun-28-19 05:24PM  
Jun-25-19 09:28AM  
Jun-21-19 09:17AM  
May-23-19 05:36PM  
06:00AM  
May-22-19 07:55PM  
06:50PM  
06:42PM  
May-16-19 01:15PM  
May-09-19 10:30AM  
May-07-19 12:50PM  
Apr-25-19 04:36PM  
Apr-11-19 11:26AM  
Mar-21-19 08:16AM  
Mar-20-19 10:30AM  
Mar-12-19 10:29AM  
Mar-08-19 08:40AM  
Mar-06-19 10:04AM  
Mar-05-19 07:23AM  
Mar-04-19 09:54AM  
09:54AM  
Feb-13-19 08:19AM  
Feb-07-19 08:08AM  
Feb-06-19 08:25PM  
07:21PM  
07:00PM  
Jan-31-19 02:00PM  
Jan-30-19 10:31AM  
Jan-24-19 10:53AM  
Jan-15-19 05:00PM  
Dec-20-18 09:39AM  
Dec-17-18 07:30AM  
Dec-07-18 05:04PM  
Dec-03-18 11:57AM  
Nov-05-18 06:35PM  
05:32PM  
04:05PM  
Nov-02-18 11:41AM  
Oct-30-18 10:33AM  
Oct-29-18 03:15PM  
Oct-11-18 08:53AM  
Sep-28-18 05:10PM  
07:37AM  
Sep-11-18 08:21AM  
Sep-06-18 08:38AM  
Aug-09-18 07:55PM  
06:48PM  
05:49PM  
Aug-02-18 01:44PM  
Jul-23-18 08:49AM  
Jul-10-18 10:37AM  
Jul-05-18 11:21AM  
08:54AM  
Jul-03-18 09:30AM  
Jul-02-18 08:44AM  
Taro Pharmaceutical Industries Ltd., a science-based pharmaceutical company, develops, manufactures, and markets prescription and over-the-counter pharmaceutical products in the United States, Canada, Israel, and internationally. The company also develops and manufactures active pharmaceutical ingredients primarily for use in its finished dosage form products. It offers its products for various therapeutic categories comprises allergy, analgesic, antibacterial, antibiotic, anticonvulsant, antiemetic, antifungal, anti-inflammatory, anti-cancer, antiplatelet agent, antipyretic, cardiovascular, CNS, corticosteroid, cosmetic, cough and cold, dermatology, diuretic, endocrine, gastrointestinal, laxative, narcotics, neuropathic pain, neuropsychiatric, sedative/hypnotic, and topical anti-neoplastic. The company provides its products in the form of capsule, cream, drops, emulsion, gel/gel kit, granules, injectable, lotion, oil, ointment, paste, powder/powder for solution, rectal suppository, shampoo, solution/solution for infusion, spray, suspension, syrup, tablets, toothpaste and mouthwash, topical foam, and topical solution. It distributes and sells its products directly to wholesalers, retail drug store chains, food chains, mass merchandisers, grocery chains, and other direct purchasers and customers, as well as healthcare institutions and private pharmacies. The company was founded in 1959 and is based in Haifa Bay, Israel. Taro Pharmaceutical Industries Ltd. is a subsidiary of Alkaloida Chemical Company Exclusive Group Ltd.